Skip to main content

Resting Heart Rate

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
2 programs
Cool roofN/A1 trial
Cool roofN/A1 trial
Active Trials
NCT06570993Completed288Est. Jan 2026
NCT06834893Not Yet Recruiting800Est. Sep 2027

Trial Timeline

Clinical trial activity over time

2024
2025
2026
2027
Heidelberg PharmaCool roof
Heidelberg PharmaCool roof

Clinical Trials (2)

Total enrollment: 1,088 patients across 2 trials

Assessing the Effects of Cool Roofs on Indoor Environments and Health in Colima, Mexico

Start: Apr 2026Est. completion: Sep 2027800 patients
N/ANot Yet Recruiting

Assessing the Effects of Cool Roofs on Indoor Environments and Health in Niue

Start: Sep 2024Est. completion: Jan 2026288 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.